Taking a genetic approach to targeting this protein, siRNA silencing of VDAC1 resulted in decreased MMP and ATP levels in cancer cell lines, as well as a drastic reduction of tumour burden on lung cancer xenografted mice [87]. The gene discussed is VDAC1; the disease is cancer.